11 VALIDATION OF CLINICAL PARAMETERS ON THE 15-YEAR LONG-TERM OUTCOME OF A TRIMODALITIY TREATMENT AND SELECTIVE ORGAN PRESERVATION FOR INVASIVE BLADDER CANCER
25 March 2010 | page 37
Supplements
European Urology Supplements
Volume 9, issue 2, pages I-XX, April 2010Viewing articles 21-30 of 1092
topAbstracts
12 PARTIAL CYSTECTOMY AFTER INDUCTION CHEMORADIOTHERAPY POSSIBLY IMPROVES ONCOLOGICAL OUTCOMES OF SELECTIVE BLADDER-SPARING PROTOCOL AGAINST MUSCLE-INVASIVE BLADDER CANCER
25 March 2010 | pages 37 - 38
14 ACCELERATED METHOTREXATE, VINBLASTINE, DOXORUBICIN, CISPLATIN (MVAC) NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A REVIEW OF TWO UK CENTRE EXPERIENCES
25 March 2010 | page 38
15 FEASIBILITY OF ADOPTIVE T-CELL BASED IMMUNOTHERAPY IN THE FIRST TWELVE PATIENTS WITH ADVANCED UROTHELIAL URINARY BLADDER CANCER
25 March 2010 | page 38
16 THE IMPACT OF C-REACTIVE PROTEIN KINETICS ON SURVIVAL IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA TREATED WITH GEMCITABINE, ETOPOSIDE AND CISPLATIN
25 March 2010 | page 39
17 DISEASE PROGRESSION WHILE UNDERGOING NEO-ADJUVANT CHEMOTHERAPY FOR TCC: WHO'S AT RISK?
25 March 2010 | page 39
18 THE EFFECT OF TESTOSTERONE TREATMENT ON PROSTATE HISTOLOGY AND APOPTOSIS IN MEN WITH LATE-ONSET HYPOGONADISM
25 March 2010 | page 39
19 SIXES CORES PROSTATE BIOPSY. FOR WHOM IT IS STILL JUSTIFIED AS INITIAL DIAGNOSTIC TOOL FOR DETECTION OF THE PROSTATE CANCER?
25 March 2010 | page 40
20 SMALLER PROSTATE VOLUME IS A RISK FACTOR OF HIGH GRADE PROSTATE CANCER DETECTED BY THE THREE-DIMENSIONAL 26-CORE BIOPSY
25 March 2010 | page 40
Viewing articles 21-30 of 1092
Copyright © 